104
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
February 28, 2010
Dynalink®-E everolimus-eluting peripheral stent
Stenting of atherosclerotic de novo or restenotic lesions (\> 50% stenosis) in the native superficial femoral or proximal popliteal artery
Dynalink®-E, everolimus-eluting peripheral stent
Stenting of atherosclerotic de novo or restenotic lesions (\> 50% stenosis) in the native superficial femoral or proximal popliteal artery
Allgemeines Krankenhaus der Stadt Wien- AKH Wien, Vienna
ZOL St. Jan, Ghent
University Hospital, Ghent
Landeskrankenhaus Klagenfurt, Klagenfurt
The Jewish Hospital Berlin, Berlin
University Hospital Tübingen, Tübingen
Herzzentrum Bad Krozingen, Bad Krozingen
Casa di Cura di Montevergine, Mercogliano
Sint Blasius Hospital, Dendermonde
Herzzentrum Leipzig, Leipzig
Lead Sponsor
Abbott Medical Devices
INDUSTRY